Skip to content

Diaphragmatic Thickness and Functional Exercise Capacity in Lobectomy Surgeries With Thoracotomy and VATS

Evaluation of Respiratory Muscle Strength, Diaphragmatic Thickness and Functional Exercise Capacity in Lobectomy Surgeries With Thoracotomy and VATS

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05669196
Enrollment
42
Registered
2022-12-30
Start date
2021-01-04
Completion date
2021-12-27
Last updated
2022-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Muscles, Thoracic Surgery, Video Assisted Thoracoscopic Surgery

Keywords

Lung cancer, functional capacity

Brief summary

The most commonly treatment for early stage non-small cell lung cancer (NSCLC) is lobectomy. Different surgical interventions during lobectomy are thought to have different effects on respiratory functions and exercise capacities. The aim of this study was to evaluate respiratory muscle strength, functional exercise capacity, and diaphragmatic thickness in groups that underwent lobectomy with standard thoracotomy, muscle sparing thoracotomy, and video-assisted thoracic surgery (VATS).

Detailed description

The most commonly treatment for early stage non-small cell lung cancer (NSCLC) is lobectomy. Different surgical interventions during lobectomy are thought to have different effects on respiratory functions and exercise capacities. The aim of this study was to evaluate respiratory muscle strength, functional exercise capacity, and diaphragmatic thickness in groups that underwent lobectomy with standard thoracotomy, muscle sparing thoracotomy, and video-assisted thoracic surgery (VATS). In this study we will evaluate respiratory muscle strength, functional exercise capacity, diaphragmatic thickness, postoperative pulmonary complications, pain, dyspnea, pulmonary function, functional status, anxiety and depression.

Interventions

None listed

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Being a lung cancer patient scheduled for standard thoracotomy, muscle sparing thoracotomy, or lobectomy with VATS, * Being clinically stable, * Volunteering to participate in the study, * be between the ages of 18-75, * To be cooperative in the tests to be done.

Exclusion criteria

* Having an orthopedic and neurological condition that prevents walking, - Having undergone any surgery on the thoracic wall, * Diagnosed with small cell lung cancer.

Design outcomes

Primary

MeasureTime frameDescription
Respiratory muscle strength (inspiration) changeThe day before the operation.Respiratory muscle strength will measure by measuring mouth pressure and using maximal inspiratory pressure (MIP) values. Preoperative and postoperative value differences will be calculated.
Respiratory muscle strength (expiration) changeThe day before the operation.Respiratory muscle strength will measure by measuring mouth pressure and using maximal expiratory pressure (MEP) values. Preoperative and postoperative value differences will be calculated.

Secondary

MeasureTime frameDescription
Postoperative Pulmonary ComplicationPostoperative first-fifth days.Postoperative pulmonary complications will be evaulate by Melbourne Group Scale. If more than 4 parameters are positive, it will be considered as having postoperative pulmonary complication.
Functional exercise capacityThe day before the operation.6-minute walk test (6MWT) will be used to evaluate functional exercise capacity.
Postoperative painThe operative day after the operation.Visual anolog scala will be used to measure pain. Zero is considered as no pain an ten s considered as no maximal pain.
DyspneaThe day before the operation.Dyspnea will be evaulate by Modifiye Medical Research Council Dyspnea Scale (mMRC).
Pulmonary function (FVC)The day before the operation.Pulmonary function will be evaulate by pulmonary function test. FVC will be measured in liter.
Pulmonary function (FEF25-75)The day before the operation.Pulmonary function will be evaulate by pulmonary function test. FEF25-75 will be measured in liter.
Pulmonary function (PEF)The day before the operation.Pulmonary function will be evaulate by pulmonary function test. PEF will be measured in liter.
Functional StatusThe day before the operation.Karnofsky Performance Status Scale will be used to evaluate functional status. It will be used i to assess the preoperative condition.
Anxiety and DepressionPostoperative first-fifth days.Anxiety and depression will be evaulate by Hospital Anxiety and Depression Scale. 7 of the survey questions question depression and 7 of them question anxiety.
Pulmonary function (FEV1)The day before the operation.Pulmonary function will be evaulate by pulmonary function test. FEV1 will be measured in liter.
Diaphragmatic thicknessThe day before the operation.Ultrasound will be used to measure diaphragmatic thickness.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026